Clinical Trial Update: A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Avastin (bevacizumab) plus taxane-based therapy for locally recurrent or metastatic breast cancer has completed, with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Locally Recurrent Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Taxane-based chemotherapy

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-05-25